TrialBMC nephrology2019

A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis.

Christine K Bailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.